CARISMA THERAPEUTICS INC Share Price
CARMCARISMA THERAPEUTICS INC Stock Performance
Open $0.16 | Prev. Close $0.28 | Circuit Range N/A |
Day Range $0.15 - $0.17 | Year Range $0.14 - $1.27 | Volume 28,571 |
Average Traded $0.16 |
CARISMA THERAPEUTICS INC Share Price Chart
About CARISMA THERAPEUTICS INC
Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidate includes CT-2401, which is in preclinical trail for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. In addition, it develops in vivo CAR-M cell therapy to treat solid tumors, including hepatocellular carcinoma. Carisma Therapeutics, Inc. has collaboration and license agreement with ModernaTX, Inc. to address oncology gene therapies. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. Carisma Therapeutics, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
CARISMA THERAPEUTICS INC Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Oct-25 | $0.16 | $0.15 | -46.07% |
09-Oct-25 | $0.27 | $0.28 | +3.32% |
08-Oct-25 | $0.27 | $0.27 | +3.44% |
07-Oct-25 | $0.25 | $0.26 | +2.75% |
06-Oct-25 | $0.24 | $0.26 | -3.41% |
03-Oct-25 | $0.26 | $0.26 | +1.15% |
02-Oct-25 | $0.27 | $0.26 | +1.95% |
FAQs on CARISMA THERAPEUTICS INC Share Price
Can I buy CARISMA THERAPEUTICS INC shares in India?
What is the share price of CARISMA THERAPEUTICS INC?
What is the 5 year returns of CARISMA THERAPEUTICS INC?
What are the high & low stock price of CARISMA THERAPEUTICS INC today?
What is the 52-week high and low of CARISMA THERAPEUTICS INC stock?